- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Thyroid Disorders
The Endocrinology Network® Thyroid Disorders clinical resource center offers readers insight and perspective into the latest from management of hypothyroidism, hyperthyroidism, thyroid cancers, and other thyroid disorders. One of the most common disorders seen by endocrinologists and those practicing in endocrinology, our thyroid disorders resource center hosts content related to FDA approvals, the latest studies, and guideline updates in management of thyroid disorders.
Generic Levothyroxine as Effective as Brand Name for Achieving Thyrotropin Goals
October 01, 2020
Study suggests generic levothyroxine achieved similar rates of patients with thyrotropin levels in the ideal range as brand name levothyroxine.
Synthetic Medication, Desiccated Thyroid Similar in Effectiveness for Hypothyroidism
September 21, 2020
Results of the study offer clinicians greater insight and could improve decision-making in regards to treatment choices for hypothyroidism.
Study Finds Thyroid Inflammation Tied to Anxiety Disorders
September 19, 2020
A study from e-ECE 2020 suggests thyroid inflammation could put patients at greater risk for developing an anxiety disorder.
Nearly 1-in-3 of Physicians Could Be Overusing Thyroid Ultrasonography
August 14, 2020
A survey of more than 600 physicians found many endorsed the use of thyroid ultrasonography for clinically unsupported reasons.
Risk of Solid Cancer Death Not Influenced by Hyperthyroidism Treatment
July 24, 2020
New research is comparing the long-term risk of death from solid cancers in patients treated with radioactive iodine, antithyroid drugs, or surgery for hyperthyroidism.
Levothyroxine Fails to Provide Cardiac Benefit in Subclinical Hypothyroidism
July 21, 2020
New data disputes the findings of previous observational studies examining the effects of levothyroxine on cardiac function.
Study Reports First Known Case of Subacute Thyroiditis After COVID-19 Infection
May 21, 2020
A new case study published in The Journal of Clinical Endocrinology & Metabolism, reports on an 18-year-old patient with COVID-19 infection and subacute thyroiditis.
L-Thyroxine Ineffective In Patients With Subclinical Hypothyroidism, Study Says
May 04, 2020
The common synthetic thyroid medication L-thyroxine has been shown to be ineffective in reducing symptoms in patients with subclinical hypothyroidism (SCH), according to a study published in the Annals of Internal Medicine.
VIDEO: Teprotumumab Offers Hope for Thyroid Eye Disease Patients
April 14, 2020
New research shows teprotumumab can be a beneficial treatment for patients suffering from thyroid eye disease (TED), even across age, gender and risk factor-based subgroups. In an interview with HCPLive®, Raymond Douglas, MD, PhD, director of the Orbital and Thyroid Eye Disease Center at the Cedars-Sinai Medical Center, explained the importance of the teprotumumab in treating this patient group and how the coronavirus disease 2019 (COVID-19) might impact thyroid eye disease patients.
First Treatment for Thyroid Eye Disease Approved by FDA
January 22, 2020
The FDA announced yesterday that it has approved the first treatment for thyroid eye disease: teprotumumab-trbw (Tepezza, Horizon Therapeutics).